This paper reports the clinical experience of a multi-center, multiple physician trial with a novel fractional radiofrequency ablative skin resurfacing and rejuvenation device (Fractora, Invasix, Israel) deployed on both Caucasian skin types I -III and Asian skin type IV. Histological study demonstrated deep ablation and collagen restructuring in the papillary and reticular dermis. The Fractora device combines the more "cone shaped" ablation seen with CO 2 and Erbium lasers with a deep non-ablative heating pattern, seen with other bipolar RF fractional needle resurfacing devices. Ablation, coagulation zones and healing dynamics are analyzed for different energy settings. Two different treatment protocols are suggested: one for light skin and then one for darker skin with a higher risk of post-inflammatory hypperpigmentation. Treatment results show improvement in skin texture, pores, wrinkles and skin dyschromia.
Introduction
Since its inception in the 1990's, carbon dioxide (CO 2 ) laser resurfacing has enjoyed the distinction of being the gold standard in the treatment of rhytides, texture concerns, acne scars and photo-damage skin. Numerous peer reviewed articles documenting its excellent long-term skin resurfacing results have been reported [1] [2] [3] [4] [5] [6] [7] [8] . One of the unique characteristics of the CO 2 laser is that it creates almost equal degrees of ablation, coagulation and residual sub-necrotic thermal zones in the skin with volumes of 50 -100 microns [3] . Although full surface CO 2 laser ablation provides some highly regarded results in the treatment of wrinkles, acne scars and photo-damage, it also presents some disadvantages. These problems include a long recovery period, prolonged erythema, uncertain wound healing characteristics derived from the re-epithelialization process, post-inflammatory hyperpigmentation in darker skin types, and long-term hypopigmentation in the majority of patients [9] [10] [11] [12] .
In response to the disadvantages of ablative CO 2 and Erbium YAG lasers, the era of non-ablative near-infrared wavelength lasers and radiofrequency devices arose for sub-necrotic tissue heating inducing collagen remodeling [13, 14] . All of these non-ablative technologies worked through targeting the relatively thick dermal layer of skin, sometimes in combination with external cooling, to preserve the epidermal skin surface from damage and create significant heating in the sub-dermal space. With the correct parameters and wavelengths, the temperature in the dermis can be very close to necrotic levels, inducing collagen remodeling and delivering modest results for skin tightening and wrinkle reduction. With the "non-ablative" approach to skin enhancement, multiple treatments were usually required and results were generally less dramatic than ablative therapies. Clinical data suggests that RF based devices provide stronger tightening effect [15] [16] [17] [18] , through the ability to penetrate more deeply into the sub-dermal space, while laser penetration depth is limited by the dermis.
Fractional skin resurfacing with non-ablative near infrared laser wavelengths were introduced in 2004, in an effort to deliver high non-ablative columns of energy into the dermis, creating micro-coagulation zones and collagen remodeling, but leaving a significant portion of the adjacent skin untreated to act as a healing reservoir of cells for the non-ablative micro-coagulation zones [19] . The first of the fractional devices were in the near-to midinfrared wavelengths range including 1550 nm Erbium lasers, 1320 nm and 1440 nm wavelengths Nd: YAG la-sers [19] [20] [21] .
In order to produce more significant results than could be achieved with fractional non-ablative coagulative devices, the ablative technologies, like CO 2 , used a fractionated approach to create ablation columns with depth up to 2 mm. These fractional ablative lasers provided the outcome advantages of ablative technique, but with improved recovery and minor risk of side effects. Fractional CO 2 and other fractionally ablative wavelengths have shown excellent improvements in wrinkles, photo-aging and acne scars [22] [23] [24] [25] [26] [27] . With the advent of ablative fractional CO 2 , Thulium and Erbium ablative lasers, dramatic improvement in skin discoloration, texture, wrinkles and acne scars with short downtime and low rate of side effects can be achieved in a single treatment with only several days of recovery time or no downtime and multiple lower fluence treatments.
More recently, alternative ablative technology was introduced that fractionates radiofrequency (RF) energy for skin resurfacing. It creates a low density fractional epidermal and superficial dermal coagulation under the conductive pins and delivers RF travelling through the reticular dermis combining a low density ablative effect in the epidermis with sub-necrotic heating in deeper layers of the skin [28] . This fractional RF approach, with relatively low impact epidermal-junctional effect and deep dermal effect, has been coined fractional "sublative resurfacing". This relatively comfortable treatment demonstrates improvement in lines, acne scars and pigmentation after multiple treatment sessions. The technology compromises with treatment efficiency in comparison to deep ablative fractional lasers, but due to deeper collagen remodeling delivers consistent results after a number of non-aggressive treatment sessions and is particularly good for tissue tightening and some results in acne scar treatment.
This paper reviews the results of using a new fractional RF ablative technology, Fractora (Invasix Ltd.), on Caucasian skin types I -III and Asian skin type IV. Fractora introduces RF energy to the reticular dermis through ablative craters that reproduce the ablative effects of a fractional CO 2 laser and an expanded zone of sub-necrotic dermal heating seen with the non-ablative lasers and RF devices. The Fractora combines in one treatment the histological and clinical benefits of epidermal-dermal dominant ablative "cone" type laser resurfacing with the pyramidal shape sublative dermal effect seen with other fractional RF systems. The combined effect of the new technology does not appear to be limited only to skin tightening, wrinkles and acne scar improvement, but initial work appears to provide a synchronous fractional RF improvement in melanin pigmentation, facial telangiectasia, and active acne. The fractional RF device described in this article may also serve to deliver ablative and rejuvenative outcomes in more difficult dyschromia prone skin type IV patients.
Materials and Methods
The Fractora hand piece used in this study is powered by the BodyTite platform (Invasix, Israel). The Fractora hand pieces come in an array of sharp RF conductive needles. Each needle is 600 µ long and 100 µ wide. There is a 60 pin tip array that provides 10% surface coverage and a 20 pin tip for the lower lid, upper lid, lip lines and vascular lesions. RF energy per pin and repetition rate is set on the interface prior to treatment. Energy per pin was varied depending on the skin type and thickness. For light skin types I -III and thick skin 50 -62 mJ/pin was applied, while for darker skin type IV patients and thinner skin 10 -40 mJ/pin was used.
With the Fractora electrode geometry (Figure 1 ), in addition to the typical "cone shaped" ablative injury seen with CO 2 , Fractora pins also acts as an array of multiple bipolar electrodes and each sends RF energy through the whole thickness of the papillary and reticular dermis, from the tip of the ablative pin effects to the side flat rail electrodes. This non-ablative, non-specific dermal matrix heating adds a very significant potential of additional skin tightening, that one does not receive with traditional laser fractional ablative treatment. The resulting "double injury" of this device is combination of a "cone shaped" superficial epdiermal-dermal ablation seen with CO 2 , combined with a dense woven matrix of deep dermal heating in a pyramidal distribution (Figure 1) .
20 Caucasian (skin types I -II) and 30 Asian patients (skin types III -IV) with an age range of 21 -70 years old, received a single full face, ablative fractional radiofrequency treatment using the Fractora hand piece. All patients were observed 3 and 6 months following treatment. For pain control some Caucasian patients treated with high parameters (40 -60 mJ/pin) underwent subcu- taneous hypodermal tumescent infiltrative anesthesia with a mixture of 1 bottle of 1% lidocaine mixed in 500 ml of Ringers lactate and 1 ml of epinephrine 1:1000. Approximately 150 cc of infiltrate was used in the hypodermal space of the brow, cheek and lower face and another 100 cc if the neck was treated. Prior the tumescent hypodermal infiltrative anesthesia, supra-orbital, infraorbital, zygomatical facial, temporal, and mental nerve blocks were performed with 10cc of 1% xylocaine. At medium settings (30 -40 mJ/pin) nerve blocks, topical anesthesia and a Zimmer cold air cooler were used, while at low energy settings (10 - 
RF energy settings used for Asian and Caucasian patients differed significantly. For Caucasian patients, the energy per pin was varied depending on skin type and thickness. For light and thick skin types I -III patients, 50 -62 mJ/pin was applied, while for darker skin type IV and thinner skin patients, 30 -40 mJ/pin was used. In most cases a single treatment was effective enough at high energy settings to achieve the treatment objectives.
For Asian patients the energy per pin was varied in the range of 10 -20 mJ/pin at the first treatment and was gradually increased up to 30 -40 mJ/pin over the next 3 treatments, performed once a month intervals. It was discovered that after several treatments the skin tone of Skin type IV patients became lighter and more uniform, allowing for the application of higher energies at subsequent treatments. For lighter skin tones and younger patients, higher energy was used, while more conservative parameters were selected for darker and older patients.
Antibiotic ointment was applied immediately after the office based treatment. At home, Aquaphor was used to keep the skin moist and until the fractional injury had healed over (usually at 2 -5 days) at which camouflage make-up could be applied. Standard Herpes Simplex prophylaxis consisting of 500 mg of Valtrex orally twice daily for 7 days was used. Standard photographs were taken prior to the treatment and at the 6 month follow up appointments. Patients were advised to take a few days off following the treatment.
Following the treatment and depending upon the parameters, intense edema and erythema were observed and lasted for several hours and up to 1 week, with a minor degree of edema being observed for up to 2 weeks. Small crusted dots, representing the ablated epidermal-dermal tissue at the opening of the ablative crater, appeared the next day following the treatment and were observed up to 1 -2 weeks after the procedure before flaking off.
Histological samples were taken immediately after treatment and at 1 week, 2 and 6 weeks post treatment to analyze character of fractional lesions and the wound healing process. Samples stained with hematoxylin and eosin show classic signs of fractional carbon dioxide ablative coagulated tissue (a), phagocytosis and healing (b) and collagen remodeling (c). Because different groups of patients are required for different treatment parameters, the histological study consists of 3 energy settings: 10 mJ/pin, 30 mJ/pin and 60 mJ/pin.
Histology images shown in Figure 2 presents treatment results and healing process after the Fractora fractional ablative RF treatment with energy settings of 60 mJ/pin. Histology of this treatment demonstrated a typical, strong, "cone shaped" epidermal-dermal dominant ablation effect as shown in Figure 2(a) . The ablation crater depth is about 500 -600 µ in depth, going through the epidermis, the papillary dermis to the mid-and deep reticular dermis. The architecture and shape of the zone of ablation is a typical "cone shaped" lesion (smaller at the base), also seen with CO 2 ablative lasers. The zone of coagulation measures 60 -100 µ surrounding ablation crater (Figure  2(a) ).
Figure 2(b) shows phagocytosis in the healing crater (zone of ablation) at 1 week follow-up. Figure 2(c) shows the treated zone structure at 6 weeks post treatment. The phagocytosis is mostly completed and initiation of new collagen formed in the healed crater and around.
At medium energy settings the ablation crater is more shallow, reaching 300 -400 µ in depth (Figure 3(a) ). When using lower energy the ablation crater ablative depth is approximately 200 -250 µ (Figure 4(a) ). Similarly, phagocytosis is less active when using lower energy settings (Figure 3(b) ) and is completed after one week when using minimal (Figure 4(b) ), indicating much faster healing. Collagen remodeling is observed even at minimal energy (Figure 4(c) ), but it is more superficial.
Highest energy histologies taken 1 week following treatment is presented in Figure 5 . The histology shows the skin with multiple fractional zones and collagen contraction and remodeling in the deep dermal space between the craters, supporting the effect of RF sub-necrotic heating through the entire dermal matrix, from the RF current that flows from the ablative pins to the side rail electrodes. This pyramidal zone of sub-necrotic collagen tightening and remodeling is reflective of the "sublative effects" seen with other frac ional RF pin technologies t [28]. Fractora is unique in that it combines the strong epidermal "cone shaped" ablation of carbon dioxide with the deep non-ablative tightening, or "sublative" effects seen with fractional RF devices that have a relatively low epidermal impact. Treatment results and before and after photographs of each patients individual improvement were analyzed and scored using software driven photographic analogue scoring devices for the following clinical concerns:  Tightening of lax skin;  Improvement in wrinkles and lines;  Skin texture improvement;  Reduction in pore size;  Improvement in pigmented lesions and skin tone;  Reduction in facial telangiectasia; non-satisfied with treatment results, 10 patients mildly satisfied, 14 patients satisfied, 18 patients happy with results and 7 patients extremely happy. Figure 6 shows a female patient before and 4 months after a full-face Fractora treatment. The Fractora treatment was delivered at 60 mJ/pin and the before and after photographs demonstrate skin tightening, peri-oral wrinkle reduction and an overall improvement of skin quality. Figure 7 shows a Caucasian patient before and 6 months after a full-face Fractora treatment. The energy delivery was 60 mJ/pin and the treatment demonstrated a significant reduction of pigmented lesions (comparable with an IPL treatment), reduction of peri-oral lines and significant improvement of skin quality. Figure 8 shows a male patient before and immediately after Fractora treatment on vascular lesions. Figure 9 illustrates an Asian 50 years old male with skin type IV before the treatment and 3 months following the last treatment. The patient received 2 treatments with a gradual energy increase from 10 mJ/ pin at the first treatment up to 25 mJ/pin at the second treatment. Improvement of peri-orbital lines, skin texture and skin tightening was indicated 3 months following the last treatment. The results are presented in Table 1 .
Conclusions
This study confirms the efficacy and safety of a novel RF fractional ablative device. The histological results confirm the compatibility of Fractora treatment outcomes and many of the clinical skin enhancement that are seen with fractional CO 2 resurfacing. The Fractora has the additional benefits of a strong, bipolar RF non-ablative, noncoagulative dermal matrix stimulation not seen with ablative lasers. Fractora also reduces superficial and middermal melanin pigmentation. We also documented a reduction of facial telangiectasia in Caucasian patients, however future studies are recommended on a higher number of patients to fully assess the vascular reduction and paameters required. The review of patients 3 -6 months r following treatment confirms that the Fractora delivers significant improvements in wrinkles, laxity, brown pigmentation, skin tightening and acne scars. The safety profile was excellent with no significant adverse events. Patients with skin type IV appear as suitable candidates for treatment using the graduated low fluence parameters set out in this paper without an excessive risk of post inflammatory hyper-pigmentation (PIH) or hypo-pigmentation when receiving gradual energy increase over the series of treatment sessions or accompanied with melanocyte suppression management regimen prior and post treatment.
Fractional ablative RF treatment with a deep needle based delivery system is a novel and unique fractional, ablative technology that provides a total skin rejuvenation solution:
1) Stimulates and produces the wrinkle reduction and skin tightening seen with ablative fractional CO 2 resurfacing;
2) Provides additional non-ablative, bipolar dermal matrix thermal stimulation which provides additional skin tightening similar to non-ablative RF devices;
3) Improves pigmented lesions and dyschromia similar to intense pulsed light; 4) Potentially improves superficial vascular lesions (additional study with higher statistics is required to determine consistency);
All patients re-epithelialized within 4 -7 days. There were no cases or instances of delayed healing, no significant adverse reactions and specifically, no hypo-pigmentation, PIH and no hypertrophic/hypotrophic scars.
The fractional RF multi-needle technology appears to be a suitable for facial treatment of both Caucasian and Asian patients.
